Research Updates from Eisai

Sunday, December 5, 2021
-

View Poster

You may need to log in to view video on this page.

OVERVIEW:

Research Updates from Eisai, Educate HCPs on the following: 

  • Perampanel applicability as a broad-spectrum agent by demonstrating efficacy and safety in achieving convulsive seizure freedom across different seizure types (SGTC and PGTC)  

  • Perampanel efficacy and safety in different patient populations; elderly; pediatric; females/pregnancy; etc 

  • Perampanel use in the real-world setting  

  • Perampanel efficacy & safety as monotherapy and first add-on therapy  

  • Management of perampanel AE profile with different titration strategies 

  • Seizure reduction and seizure freedom with use of low dose perampanel  

  • Economic value related to treatment with perampanel vs other ASMs, including reduced costs to the healthcare system  

Exhibitor: Eisai Inc. 

Activity Type
Scientific Exhibit
Credit
Non-CME
Format
In person
Career Stage
Early Career (typically 0-5 years from completion of training)
Mid-Career (typically 6-15 years from completion of training)
Senior (typically >15 years from completion of training)
Audience
Behavioral Health Providers
Clinicians
Fellows/Trainees
Nurses
Scientists/Researchers
Advanced Practice Providers
Advocates
Pharmacists
Technicians
Demographic
Clinical
First-time Attendees
Research
Young Professionals